Compositions and methods for treating thyroid disease
AssigneeScript Essentials, LLC
InventorSuzy Cohen
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a compound and method of using such compound, preferably in the form of a dietary supplement that, when administered, is capable of treating thyroid disease and various thyroid-related disorders, such as Hashimoto's thyroiditis. The unique combination of the composition is preferably administered orally via acid resistant or enteric-coated capsule, soft gel or tablet. The composition is preferably comprised of at least Catalase, Reduced Glutathione, Acetylated Glutathione, DPP-IV protease enzyme, Pepsin, Bromelain, Pancreatin, Vitamin D, and Selenium. The composition can further comprise a palliative agent, and can be provided in specific dosages or administered in forms besides those listed above.
Claims20
A composition for treating a thyroid disorder comprising:
- selenium;
- a digestive enzymes DPP-IV;
- proteolytic enzyme;
- systemic enzyme;
- and
- glutathione.
A method to manufacture a composition for treating a thyroid disease, comprising:
- mixing selenium, a digestive enzymes DPP-IV, proteolytic enzyme, systemic enzyme. and glutathione to form a mixture;
- and
- compressing the mixture in a capsule.
A method to treat a patient with an autoimmune disease, comprising:
- providing the patient with a capsule, wherein the capsule comprises:
- from about 25 to 200 mcg of selenium;
- from about 100 to 500 mg the reduced glutathione;
- and
- from about 10 to 200 mg of acetylated glutathione;
- from about 10 to 1,000 mg DPP-IV enzyme;
- from about 50 to 500 mg bromelain;
- and
- from about 50 to 500 mg Pancreatin enzyme.
Dependencies are inferred from the claim text.